USPTO serial 75366996
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | physician-prescribed pharmaceutical preparation for the treatment of dyslipidemia | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 19, 2007 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Dec 1, 2005 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 14, 2005 | PAPER RECEIVED | — | |
| Dec 21, 1999 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 19, 1999 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Sep 30, 1998 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 1, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 15, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 12, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 1997 | DOCK | ASSIGNED TO EXAMINER | — |